Stage 2 prostate adenocarcinoma is localized, with a nearly 100% five-year relative survival rate. Diagnosis uses the TNM system, PSA levels, and Gleason score to determine cancer stage and risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback